ARCHIVES

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

NCI Advisory Group, Other Cancer Meetings

February 24, 1989